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Abstract
Background:  The phenomenon of misdiagnosing tuberculosis (TB) by laboratory cross-
contamination when culturing Mycobacterium tuberculosis (MTB) has been widely reported and it has
an obvious clinical, therapeutic and social impact. The final confirmation of a cross-contamination
event requires the molecular identification of the same MTB strain cultured from both the potential
source of the contamination and from the false-positive candidate. The molecular tool usually
applied in this context is IS6110-RFLP which takes a long time to provide an answer, usually longer
than is acceptable for microbiologists and clinicians to make decisions. Our purpose in this study
is to evaluate a novel PCR-based method, MIRU-VNTR as an alternative to assure a rapid and
optimized analysis of cross-contamination alerts.
Results: MIRU-VNTR was prospectively compared with IS6110-RFLP for clarifying 19 alerts of
false positivity from other laboratories. MIRU-VNTR highly correlated with IS6110-RFLP, reduced
the response time by 27 days and clarified six alerts unresolved by RFLP. Additionally, MIRU-VNTR
revealed complex situations such as contamination events involving polyclonal isolates and a false-
positive case due to the simultaneous cross-contamination from two independent sources.
Conclusion:  Unlike standard RFLP-based genotyping, MIRU-VNTR i) could help reduce the
impact of a false positive diagnosis of TB, ii) increased the number of events that could be solved
and iii) revealed the complexity of some cross-contamination events that could not be dissected by
IS6110-RFLP.
Background
The false diagnosis of tuberculosis (TB) due to laboratory
cross-contamination is a well-known phenomenon and
has been reported to occur in 0.1–3% of cases [1-5]. It has
an obvious epidemiological, clinical and therapeutical
impact -each misdiagnosis of tuberculosis due to labora-
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tory cross-contamination has been estimated to cost on
average 10,872 dollars [6]. We recently presented data
indicating that laboratory cross-contamination events are
more frequent than expected [7] and that these alerts
require a faster clarification. False positivity due to labora-
tory cross-contamination is suspected when i) Mycobacte-
rium tuberculosis (MTB) is cultured from only one of the
serial specimens of a patient, ii) the bacterial yield in the
culture is low and iii) the suspected sample has been proc-
essed together (or in a short period of time apart) with at
least one other from a patient with a high bacterial load.
The final confirmation of false positivity requires the
application of molecular tools to prove that the MTB iso-
lates from the co-processed specimens share identical gen-
otypic patterns (after having ruled out epidemiological
links between the cases involved). Unfortunately, the ref-
erence MTB genotyping method, IS6110-RFLP, requires
well-grown cultures and takes a long time to provide an
answer, usually longer than is acceptable for microbiol-
ogists and clinicians to make decisions.
A rapid PCR-based MTB genotyping tool, MIRU-VNTR
(Mycobacterial-interspersed-repetitive-units-Variable-
number-tandem-repeats) [8], has recently been developed
and has proved useful in different epidemiological studies
[9,10]. It could allow quicker resolution of cross-contam-
ination alerts although studies evaluating the efficiency of
MIRU-VNTR in this context in a prospective design are
lacking, and only a few isolated examples of its potential
in identifying false-positive cases have been reported [11].
Our purpose in this study is to evaluate MIRU-VNTR as an
alternative to assure a rapid analysis of cross-contamina-
tion alerts in reference laboratories.
Results and Discussion
We prospectively evaluated whether MIRU-VNTR could
be an alternative to RFLP for the fast resolution of labora-
tory cross-contamination alerts in reference genotyping
centres. Therefore, we applied both IS6110-RFLP and
MIRU-VNTR in a pilot study to analyze all the alerts
received from laboratories in Almería, Spain. We com-
pared the response time and the correlation between the
diagnosis of either true positivity or laboratory cross-con-
tamination using both techniques. The response time was
measured from the moment the culture was received until
MIRUtype for all the 12 loci assayed, or an RFLPtype were
obtained. We decided to accept only those results
obtained within a reasonable time frame (below 90 days),
because longer times were not considered useful for
resolving the alerts.
Between November 2005 and February 2007, 19 cross-
contamination alerts were received in our laboratory. If
the potential sources (candidates of true-positive cases)
and receptors (candidates of false-positive cases) in con-
tamination events are taken together, a total of 48 cultures
were involved (Figures 1 &2). In all cases MIRU-VNTR
resolved the alert before RFLP. The response time range
for MIRU-VNTR from the reception of the sample was 3–
28 days (median: 13 days) whereas RFLP required 24–77
days (median 45 days) (Figure 1). This means that MIRU-
VNTR reduced the standard response time by 16–60 days
(median: 27 days), which could easily have been
increased if priority had been given to performing MIRU-
VNTR analysis. Instead, we preferred to perform this eval-
uation in the real situation of a genotyping laboratory
with many other routines. The response time for MIRU-
VNTR was longer than could be expected because the pri-
mary culture had to be sent to another reference labora-
tory to perform susceptibility assays, and this meant the
reception in many cases of fresh subcultures that required
preincubation before analysis. The application of capil-
lary electrophoresis to analyze MIRU-VNTR products [8]
had also reduced the response time. With regard to the
correlation in the answers, RFLP detected false-positivity
in eight of the thirteen events in which it was able to pro-
vide a response, indicating that the cross-contamination
alerts were justified. MIRU-VNTR, even having applied the
12-loci set which is less discriminatory than the 15 or 24-
loci sets [12,13], correlated in all cases except in one alert
(alert 4) considered as true positivity by RFLP whereas
MIRU-VNTR found identical genotypes for the involved
cases. To try to clarify this discrepancy, MIRU-VNTR with
the whole set of 24 loci was applied and, again, the
involved cases shared identical MIRUtypes. A detailed
analysis of the RFLPtypes indicated that most of the bands
in alert 4 were shared and that differences could result
from the acquisition of an additional PvuII site responsi-
ble for the digestion of a long band into two smaller
bands (Figure 1). One possible explanation for this poten-
tial discrepancy would be that the potential source case
was infected by two IS6110 RFLP variants and only one
was involved in the cross-contamination event. Consist-
ent with this hypothesis, an independent specimen from
the source case was genotyped and the same IS6110 pro-
file as the one displayed in the contamination event was
observed (data not shown).
As indicated above, RFLP could not offer an answer in six
alerts, either because some of the cultures (in three alerts)
did not lead to the bacterial yield required for RFLP or
because the 90-day limit was exceeded. In all the cases that
remained unsolved by RFLP, MIRU-VNTR provided a
result and, in two of them, it identified a cross-contamina-
tion that would have gone undetected if only RFLP analy-
sis had been available. Each one of these two cross-
contamination events revealed only by MIRU-VNTR
showed interesting features (Figure 2). The first one (alert
15) involved a polyclonal isolate, with two variants in one
loci, similar to others previously reported [14]. The sec-BMC Microbiology 2008, 8:30 http://www.biomedcentral.com/1471-2180/8/30
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ond (alert 19) was a complex situation in which two cross-
contamination events occurred simultaneously. Each of
two different sources (PS1 and PS2) contaminated a spec-
imen from two independent patients (CCA1 and CCA2)
and both (PS1 and PS2) were also involved in the simul-
taneous contamination of an additional specimen from
another case (CCA3). This double contaminated case
(CCA3) could be detected by MIRU-VNTR because its pat-
tern was the combination of the MIRUtypes of the sources
(PS1 and PS2), with two different alleles in three of the
loci (Figure 2). In this alert, the 90-day limit was exceeded
by RFLP and the profiles are not shown; however, the
complex patterns of the isolates involved (14 bands and 8
bands) led to a 22-band pattern in the double-contami-
nated false-positive case that prevented identification of
false-positivity by RFLP but not by MIRU-VNTR.
Conclusion
Our data mean that MIRU-VNTR is more adequate than
RFLP for analyzing cross-contamination alerts. It was
faster than RFLP, the correlation with RFLP diagnosis was
high and it succeded in resolving alerts even under cir-
cumstances that were not appropriate for the RFLP analy-
sis requirements. A permanently suspicious attitude on
the part of the clinical mycobacteriologist together with
access to a fast resolution of cross-contamination alerts
could enable more rapid management of suspected false-
positive cases, because culture-results would only need to
be retained for a short time before clarification. Unlike
standard RFLP-based genotyping, MIRU-VNTR could help
reduce the impact of a false positive diagnosis of TB.
Methods
Samples
Clinical specimens were processed according to standard
methods and grown in Lowenstein-Jensen slants and in
MGIT (Becton Dickinson, Sparks, Md) liquid media.
The numbers for each alert were assigned chronologically. For each alert the potential source/s (PS) and the cross-contamina-
tion alerts (CCA) are indicated. The MIRUtypes and RFLPtypes and the time (days) for the obtention of results, the result
(TP:True positivity, FP: False positivity) after analyzing the MIRU-VNTR and RFLP fingerprints, and the differences between the
time for solving the alerts by MIRU-VNTR and RFLP are shown. The asterisks in alert 4 indicate the differential bands between
the RFLP patterns. The MIRU-VNTR alleles which are different for the isolates from an alert are highlighted in bold.
Analysis by MIRU-VNTR of the cross-contamination alerts that could not be solved by RFLP Figure 1
VNTR-MIRU ANALYSIS  RFLP ANALYSIS    
ALERT       MIRU-type  TIME  RESULT RFLP-type  TIME  RESULT  TIME DIFFERENCES
1 
PS:  225325153323  
CCA:225325153323 
8 FP 
  
51 FP 43 
2 
PS:   223415153323 
CCA:223326153325 21  TP      
  
48 TP 27 
3 
PS:   225325153323 
CCA:225325153323  28 FP 
  
49 FP 21 
4 
PS:   225323153423 
CCA:225323153423  13 FP 
  
29 TP 16 
5 
PS:   224213153323 
CCA:224213153323  13 FP  29 FP 16 
6 
PS:   225325153323 
CCA:225325153323  8 FP 
  
51 FP 43 
7 
PS:   224226153313 
CCA:223415143323 
13 TP 
  
29 TP 16 
8 
PS:  225313153323 
CCA:225313153323
17 FP  77 FP 60 
9 
PS1: 224325154323
CCA:224325154323
PS2: 224426163321 
5 FP  45 FP 40 
10 
PS:  323325153325 
CCA:323325153325
3 FP  24 FP 21 
11 
PS:   126325153324 
CCA:126325153324
11 FP  62 FP 51 
12 
PS:   224325163221 
CCA:225325154324 
13 TP  29 TP 16 
13 
PS1: 224325154323
CCA:224325154323 
PS2: 224426163321 
5 FP  45 FP 40 
* 
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Molecular analysis
For IS6110-RFLP we followed the standard procedures
[15], and for MIRU-VNTR we applied the 12-loci set [8],
trying to apply the simplest and fastest MIRU format and
also attempting to obtain a result by directly amplifying a
crude extract of the culture (after boiling and sonicating
for ten and five minutes, respectively). MIRU-VNTR prod-
ucts were separated by electrophoresis at 45 V for 17 h 30
min, using MS8 2% agarose gels (Pronadisa, Madrid,
Spain). Fragment sizes were calculated with the Chemi-
Doc system (BioRad, CA, USA) and the Diversity database
(BioRad), using a 100-bp ladder (Invitrogen, CA, USA) as
a molecular weight marker. The number of repeats in each
locus was calculated by applying the corresponding con-
version tables (P. Supply, personal communication)
Molecular patterns were analyzed using Bionumerics 4.6
(Applied Maths, Sint-Martens Laten, Belgium). Results
were interpreted as false positivity if both the potential
source and the cross-contamination alert had identical
MIRU-VNTR and IS6110 RFLP and the converse for true
positivity.
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